Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1996 Jun;88(2):220–229. doi: 10.1111/j.1365-2567.1996.tb00008.x

Effect of adoptive transfer of CD4, CD8 and B cells on recovery from MHV3-induced immunodeficiencies.

L Lamontagne 1, P Jolicoeur 1, D Decarie 1, J Menezes 1
PMCID: PMC1456434  PMID: 8690454

Abstract

A chronic viral infection can occur when the host fails to mount an effective immune response to clear the virus. Mouse hepatitis virus type 3 (MHV3) appears to be an excellent model for the study of the relationship between viral-induced immunodeficiency and chronic disease development. (C57BL/6 x A/J)F1 mice surviving acute hepatitis develop a chronic disease characterized by T- and B-cell immunodeficiencies, viral persistence in various organs including the brain, spleen and thymus, and death within 3 months postinfection (p.i.). We have reported that T- or B-cell deficiencies, observed in MHV3 chronically infected (C57BL/6 x A/J)F1 mice, can be partially or totally thwarted by adoptive transfer of CD4+, CD8+ and/or B cells, at 15 days p.i. in mice surviving the acute phase of the disease. Adoptive transfer of syngeneic CD4+ and/or CD8+ allowed a partial restoration of the T-cell deficiencies, as characterized by thymic atrophy, decrease in splenic T cells, and in all thymocyte subpopulations. B-cell immunodeficiency, as defined by a decrease in splenic B cells, as well as in the bone marrow pre-B- and B-cell compartments, and the occurrence of abnormally larger forms of bone marrow pre-B and B cells, were partially thwarted by B-cell treatment only. Splenic B cells and the bone marrow B-cell compartment, respectively, returned partially or totally to normal values, whereas the pre-B-cell compartment remained depleted in infected mice treated with B cells. Levels of all immunoglobulin classes returned to normal values in MHV3 chronically infected mice when treated with CD4+ in combination with CD8+ cells. All T- and/or B-cell treatments, however, were sufficient to thwart the process of the chronic disease, and favoured the survival of mice for up to 6 months p.i.

Full text

PDF
220

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boespflug O., Godfraind C., Tardieu M. Effect of cyclosporin A on an experimental chronic viral infection of the central nervous system. J Neuroimmunol. 1989 Jan;21(1):49–57. doi: 10.1016/0165-5728(89)90158-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buchmeier M. J., Lewicki H. A., Talbot P. J., Knobler R. L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984 Jan 30;132(2):261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burks J. S., DeVald B. L., Jankovsky L. D., Gerdes J. C. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science. 1980 Aug 22;209(4459):933–934. doi: 10.1126/science.7403860. [DOI] [PubMed] [Google Scholar]
  4. Casebolt D. B., Spalding D. M., Schoeb T. R., Lindsey J. R. Suppression of immune response induction in Peyer's patch lymphoid cells from mice infected with mouse hepatitis virus. Cell Immunol. 1987 Oct 1;109(1):97–103. doi: 10.1016/0008-8749(87)90295-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Castro R. F., Evans G. D., Jaszewski A., Perlman S. Coronavirus-induced demyelination occurs in the presence of virus-specific cytotoxic T cells. Virology. 1994 May 1;200(2):733–743. doi: 10.1006/viro.1994.1237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dupuy J. M., Dupuy C., Décarie D. Genetically determined resistance to mouse hepatitis virus 3 is expressed in hematopoietic donor cells in radiation chimeras. J Immunol. 1984 Sep;133(3):1609–1613. [PubMed] [Google Scholar]
  7. Fleming J. O., Shubin R. A., Sussman M. A., Casteel N., Stohlman S. A. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989 Jan;168(1):162–167. doi: 10.1016/0042-6822(89)90415-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hovi T., Kainulainen H., Ziola B., Salmi A. OC43 strain-related coronavirus antibodies in different age groups. J Med Virol. 1979;3(4):313–320. doi: 10.1002/jmv.1890030410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Imrich H., Schwender S., Hein A., Dörries R. Cervical lymphoid tissue but not the central nervous system supports proliferation of virus-specific T lymphocytes during coronavirus-induced encephalitis in rats. J Neuroimmunol. 1994 Aug;53(1):73–81. doi: 10.1016/0165-5728(94)90066-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jolicoeur P., Lamontagne L. Impaired T and B cell subpopulations involved in a chronic disease induced by mouse hepatitis virus type 3. J Immunol. 1994 Aug 1;153(3):1318–1317. [PubMed] [Google Scholar]
  11. Jolicoeur P., Lamontagne L. Mouse hepatitis virus 3 pathogenicity expressed by a lytic viral infection in bone marrow 14.8+ mu+ B lymphocyte subpopulations. J Immunol. 1989 Dec 1;143(11):3722–3730. [PubMed] [Google Scholar]
  12. Lamontagne L. M., Dupuy J. M. Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines. Infect Immun. 1984 Jun;44(3):716–723. doi: 10.1128/iai.44.3.716-723.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lamontagne L., Décarie D., Jolicoeur P. Immune cell tropisms of attenuated MHV3 viruses isolated from brains of chronically infected mice. Viral Immunol. 1990 Spring;3(1):1–8. doi: 10.1089/vim.1990.3.1. [DOI] [PubMed] [Google Scholar]
  14. Lamontagne L., Jolicoeur P. Mouse hepatitis virus 3-thymic cell interactions correlating with viral pathogenicity. J Immunol. 1991 May 1;146(9):3152–3159. [PubMed] [Google Scholar]
  15. Le Prevost C., Levy-Leblond E., Virelizier J. L., Dupuy J. M. Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms. J Immunol. 1975 Jan;114(1 Pt 1):221–225. [PubMed] [Google Scholar]
  16. Mobley J., Evans G., Dailey M. O., Perlman S. Immune response to a murine coronavirus: identification of a homing receptor-negative CD4+ T cell subset that responds to viral glycoproteins. Virology. 1992 Apr;187(2):443–452. doi: 10.1016/0042-6822(92)90446-V. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Park Y. H., Osmond D. G. Phenotype and proliferation of early B lymphocyte precursor cells in mouse bone marrow. J Exp Med. 1987 Feb 1;165(2):444–458. doi: 10.1084/jem.165.2.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Perlman S., Schelper R., Bolger E., Ries D. Late onset, symptomatic, demyelinating encephalomyelitis in mice infected with MHV-JHM in the presence of maternal antibody. Microb Pathog. 1987 Mar;2(3):185–194. doi: 10.1016/0882-4010(87)90020-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Prévost C. L., Virelizier J. L., Dupuy J. M. Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virologic observation of a persistent viral infection. J Immunol. 1975 Sep;115(3):640–643. [PubMed] [Google Scholar]
  20. Resta S., Luby J. P., Rosenfeld C. R., Siegel J. D. Isolation and propagation of a human enteric coronavirus. Science. 1985 Sep 6;229(4717):978–981. doi: 10.1126/science.2992091. [DOI] [PubMed] [Google Scholar]
  21. Smith A. L., Bottomly K., Winograd D. F. Altered splenic T cell function of BALB/cByJ mice infected with mouse hepatitis virus or Sendai virus. J Immunol. 1987 May 15;138(10):3426–3430. [PubMed] [Google Scholar]
  22. Stohlman S. A., Bergmann C. C., van der Veen R. C., Hinton D. R. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J Virol. 1995 Feb;69(2):684–694. doi: 10.1128/jvi.69.2.684-694.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stohlman S. A., Matsushima G. K., Casteel N., Weiner L. P. In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J Immunol. 1986 Apr 15;136(8):3052–3056. [PubMed] [Google Scholar]
  24. Sussman M. A., Shubin R. A., Kyuwa S., Stohlman S. A. T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol. 1989 Jul;63(7):3051–3056. doi: 10.1128/jvi.63.7.3051-3056.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tardieu M., Goffinet A., Harmant-van Rijckevorsel G., Lyon G. Ependymitis, leukoencephalitis, hydrocephalus, and thrombotic vasculitis following chronic infection by mouse hepatitis virus 3 (MHV 3). Acta Neuropathol. 1982;58(3):168–176. doi: 10.1007/BF00690797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wege H., Siddell S., ter Meulen V. The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol. 1982;99:165–200. doi: 10.1007/978-3-642-68528-6_5. [DOI] [PubMed] [Google Scholar]
  27. Welsh R. M., Haspel M. V., Parker D. C., Holmes K. V. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype. J Immunol. 1986 Feb 15;136(4):1454–1460. [PubMed] [Google Scholar]
  28. Wysocka M., Korngold R., Yewdell J., Bennink J. Target and effector cell fusion accounts for B lymphocyte-mediated lysis of mouse hepatitis virus-infected cells. J Gen Virol. 1989 Jun;70(Pt 6):1465–1472. doi: 10.1099/0022-1317-70-6-1465. [DOI] [PubMed] [Google Scholar]
  29. Wysocki L. J., Sato V. L. "Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2844–2848. doi: 10.1073/pnas.75.6.2844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. de Souza M. S., Smith A. L., Bottomly K. Infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic T cell proliferation and cytokine production. Lab Anim Sci. 1991 Apr;41(2):99–105. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES